{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:26:38Z","timestamp":1772223998138,"version":"3.50.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,6,7]],"date-time":"2015-06-07T00:00:00Z","timestamp":1433635200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s11096-015-0134-z","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T09:07:44Z","timestamp":1433581664000},"page":"739-743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A retrospective study of cutaneous drug reactions in an outpatient population"],"prefix":"10.1007","volume":"37","author":[{"given":"Francesco","family":"Drago","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovica","family":"Cogorno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna Fay","family":"Agnoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Ciccarese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Parodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,7]]},"reference":[{"key":"134_CR1","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"RI Edwards","year":"2000","unstructured":"Edwards RI, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255\u20139.","journal-title":"Lancet"},{"key":"134_CR2","doi-asserted-by":"crossref","unstructured":"McKenna JK, Leiferman KM. Dermatologic drug reactions. Immunol Allergy Clin North Am. 2004;399\u2013423.","DOI":"10.1016\/j.iac.2004.03.007"},{"key":"134_CR3","unstructured":"Shear HN, Knowles RS, Sullivan RJ, Shapiro L. Chapter 138, Cutaneous reactions to drugs. Fitzpatrick T, Eisen A, Wolffe K, editors. Dermatology in General Medicine, 8th ed. New York: Mc Graw Hill, p. 1330\u20131337."},{"key":"134_CR4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/0019-5154.96191","volume":"57","author":"F Akpinar","year":"2012","unstructured":"Akpinar F, Dervis E. Drug eruptions: an 8-year study including 106 inpatients at a dermatology clinic in Turkey. Indian J Dermatol. 2012;57:194\u20138.","journal-title":"Indian J Dermatol"},{"key":"134_CR5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1365-4632.2010.04785.x","volume":"50","author":"I Zaraa","year":"2011","unstructured":"Zaraa I, Jones M, Trojjet S, Cheikh Rouhou R, El Euch D, Mokni M, et al. Severe adverse cutaneous drug eruptions: epidemiological and clinical features. Int J Dermatol. 2011;50:877\u201380.","journal-title":"Int J Dermatol"},{"key":"134_CR6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0031-6997(24)01501-1","volume":"53","author":"CK Svensson","year":"2000","unstructured":"Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions. Pharmacol Rev. 2000;53:357\u201379.","journal-title":"Pharmacol Rev"},{"key":"134_CR7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1468-3083.2000.00159-5.x","volume":"14","author":"R Apaydin","year":"2000","unstructured":"Apaydin R, Bilen N, D\u00f6kmeci S, Bayramg\u00fcrler D, Yildirim G. Drug eruptions: a study including all inpatients and outpatients at a dermatology clinic of a university hospital. Eur Acad Dermatol Venereol. 2000;14:518\u201320.","journal-title":"Eur Acad Dermatol Venereol"},{"key":"134_CR8","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-2125.2010.03774.x","volume":"71","author":"BY Thong","year":"2011","unstructured":"Thong BY, Tan TC. Epidemiology and risk factors for drug allergy. Br J Clin Pharmacol. 2011;71:684\u2013700.","journal-title":"Br J Clin Pharmacol"},{"key":"134_CR9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","volume":"115","author":"S Bastuji-Garin","year":"2000","unstructured":"Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Investig Dermatol. 2000;115:149\u201353.","journal-title":"J Investig Dermatol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-015-0134-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-015-0134-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-015-0134-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:45:10Z","timestamp":1748432710000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-015-0134-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,7]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["134"],"URL":"https:\/\/doi.org\/10.1007\/s11096-015-0134-z","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,7]]}}}